Fibrogrowth factor-2 protects against acute lung injury by activating the PI3K/Akt signaling pathway

Q-Y. Tang, J-X. Wei, S-F. Xue, G-H. Liu, L-X. Fu

Article ID: 4867
Vol 34, Issue 5, 2020
DOI: https://doi.org/10.23812/20-252-A
Received: 8 November 2020; Accepted: 8 November 2020; Available online: 8 November 2020; Issue release: 8 November 2020

Abstract

Acute lung injury (ALI)/Acute respiratory distress syndrome (ARDS) is a very dangerous disease. The purpose of this study was to investigate the effects of fibrogrowth factor-2 (FGF-2) on lipopolysaccharide (LPS)-induced lung injury and its mechanisms. C57/BL6 mice were used in the study and LPS was used to construct the ALI/ARDS model. In addition, human normal lung epithelial cell line BEAS-2B was cultured to investigate the effect of FGF-2 on the lung and its mechanism of action in vitro. FGF-2 significantly reduced wet/dry weight ratio of mice, the number of cells and inflammatory factors in BALF, and MPO activity in lung tissue. In addition, FGF-2 also reduced the level of oxidative stress in mouse lung tissue. In vitro, FGF-2 effectively reduced LPS-induced inflammatory and apoptotic levels of BEAS-2B cells and increased the activity of the PI3K/Akt signaling pathway. However, LY294002, an inhibitor of the PI3K/Akt signaling pathway, alleviated the protective effect of FGF-2 on lung tissue. Therefore, FGF-2 attenuated inflammation, oxidative stress and apoptosis in alveolar epithelial cells by activating the PI3K/Akt signaling pathway.


Keywords

PI3K/Akt signaling pathway;acute lung injury;acute respiratory distress syndrome;fibrogrowth factor-2;lipopolysaccharide


References

Supporting Agencies



Copyright (c) 2020 Q-Y. Tang, J-X. Wei, S-F. Xue, G-H. Liu, L-X. Fu




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).